Merrimack Pharmaceuticals and Actavis have entered into a collaboration agreement in which Merrimack will utilize its proprietary nanoliposomal technology platform to develop and manufacture various pharmaceutical products for Actavis to commercialize around the world.
Genomic Health and ALMAC GROUP have announced that Genomic Health will exclusively license Almac Group's technology and intellectual property to further develop, validate and subsequently commercialize a multi-gene test to predict benefit from DNA damage-based chemotherapy drugs, such as the commonly used anthracycline-based regimens, in breast cancer.
A government study offers a new theory on why the whooping cough vaccine doesn't seem to be working as well as expected. The research suggests that while the vaccine may keep people from getting sick, it doesn't prevent them from spreading whooping cough — also known as pertussis — to others.
Norway-based cancer drug maker Algeta ASA says it has received a preliminary takeover offer from Germany's Bayer AG that values the company at about $2.4 billion. Algeta said in a statement Tuesday that the offer is for 336 kroner ($55.11) per share; the company has nearly 44 million shares.
The Food and Drug Administration is lifting severe safety restrictions on the former blockbuster diabetes pill Avandia, citing recent data suggesting that the much-debated medication does not increase the risk of heart attack.
The ALpHA G is an absolute rated depth type prefilter, which has been optimized for compatibility with a gamma irradiation cycle commonly used to sterilize single-use systems.
Authorities in Michigan and Massachusetts say they will coordinate their investigations of a company that sold steroid injection materials linked to a fungal meningitis outbreak that sickened hundreds of people in 20 states.
The Food and Drug Administration has ordered Google-backed genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is supported by science.
Ready-to-go straight from the box, ÄKTA start is a compact, affordable protein purification system that removes the hassles of manual approaches and provides automated control of the purification procedure.
Mylan has announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product. The product is a biosimilar to Roche's Herceptin, indicated for the treatment of HER2 overexpressing breast cancer.
Cubist Pharmaceuticals Inc. shares jumped Monday after the company said that a study of its drug for treatment of complicated urinary tract infections met its goal of showing that it works as well as existing antibiotic, levofloxacin.
The new DG25 digital pressure gauge provides a 5 full digit LCD in ranges up to 25,000 psi. Available in accuracies of 0.5% and 0.25% FS, this new design offers a minimum battery life of 2000 hours.
The RX series line of Oil-Lubricated Rotary Vane Vacuum Pumps, including central vacuum systems, are designed to help machines mix, blend, and dry. The Central Vacuum System is updated with the latest touchscreen Omron PLC technology.
Orexigen Therapeutics Inc. shares jumped Monday after the drugmaker said it expects to resubmit its application for the potential weight-loss treatment Contrave to federal regulators in the next few weeks. The La Jolla, Calif., company said Monday that the Food and Drug Administration could...
Eisai announced today that it has become a signatory to the Tuberculosis Drug Accelerator (TBDA) partnership, a ground-breaking initiative that aims to speed up the discovery of essential new treatments for tuberculosis (TB).